Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Emergent BioSolutions Inc. | Chairman, Director | Common Stock | 89.3K | $516K | $5.78 | May 23, 2024 | Direct |
Emergent BioSolutions Inc. | Chairman, Director | Stock Option (Right to Buy) | 25.7K | May 23, 2024 | Direct | ||
Aptevo Therapeutics Inc. | Director | Restricted Stock Unit | 925 | Jul 17, 2024 | Direct | ||
Aptevo Therapeutics Inc. | Director | Common Stock | 280 | Jun 2, 2024 | Direct | ||
Aptevo Therapeutics Inc. | Director | Restricted Stock Unit | 0 | Jun 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APVO | Aptevo Therapeutics Inc. | Jul 17, 2024 | 1 | $0 | 4 | Jul 19, 2024 | Director |
APVO | Aptevo Therapeutics Inc. | Jun 1, 2024 | 4 | $0 | 4 | Jun 3, 2024 | Director |
EBS | Emergent BioSolutions Inc. | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Chairman, Director |
APVO | Aptevo Therapeutics Inc. | Aug 9, 2023 | 2 | $0 | 4 | Aug 10, 2023 | Director |
APVO | Aptevo Therapeutics Inc. | Jun 1, 2023 | 3 | $0 | 4 | Jun 2, 2023 | Director |
EBS | Emergent BioSolutions Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Chairman, Director |
APVO | Aptevo Therapeutics Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 10, 2022 | Director |
APVO | Aptevo Therapeutics Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
EBS | Emergent BioSolutions Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
APVO | Aptevo Therapeutics Inc. | Jun 1, 2021 | 2 | $0 | 4 | Jun 2, 2021 | Director |
EBS | Emergent BioSolutions Inc. | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |